Skip to content
ALT Bioscience logo — Advancing diagnostic and biomedical technologies to enhance...

ALT Bioscience

Advancing diagnostic and biomedical technologies to enhance oral-systemic health and combat neurodegenerative diseases.

Founded 1997 Venture round Total: $8.15M Biotechnology, Life Sciences +1

General Information

Company Name ALT Bioscience
Founded Year 1997
Founders / Decision Makers
Team member
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with ALT Bioscience. To contact ALT Bioscience, visit perio-dx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ALT Bioscience compare?

A PDF of ALT Bioscience and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ALT Bioscience soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ALT Bioscience

ALT Bioscience is a biotechnology and pharmaceutical company that was founded in 1997 with a mission to advance diagnostic and biomedical technologies. Headquartered in Lexington, Kentucky, the company is dedicated to enhancing oral-systemic health and combatting neurodegenerative diseases. Their slogan "Advancing diagnostic and biomedical technologies to enhance oral-systemic health and combat neurodegenerative diseases" encapsulates their core focus. In June 2015, ALT Bioscience secured a significant $6.38M in their Venture Round investment, signifying a strong interest from investors in their innovative approach. As the company continues to make strides in the biotechnology and pharmaceutical industries, their dedication to advancing healthcare technologies positions them as an intriguing contender for further investment and market impact.

Business keywords: Bioscience, Diagnostic technologies, Biomedical technologies, Oral-systemic health, Neurodegenerative diseases, Research and Development, Commercialization, Life Sciences, Kentucky, Innovations

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $6.38M -
26 Jun 2015
Venture Round $920.19K -
16 Sep 2010
Venture Round $853.50K -
13 Nov 2009

ALT Bioscience Alternatives & Competitors

View All Alternatives
ALT Bioscience vs

Episozyme

1 employees
Biotechnology, Life Sciences
ALT Bioscience vs
PROGEN
PROGEN Germany

Making life sciences better. Together.

41 employees
Biotechnology, Health and Wellness
ALT Bioscience vs

Creates advanced genetically engineered systems for use inside living organisms and in laboratory se...

9 employees
Biotechnology, Life Sciences

FAQ About ALT Bioscience

Advancing diagnostic and biomedical technologies to enhance oral-systemic health and combat neurodegenerative diseases.
ALT Bioscience was founded in 1997.
ALT Bioscience operates in Biotechnology, Life Sciences and Pharmaceutical. Its work centres on Bioscience, Diagnostic technologies, Biomedical technologies and Oral-systemic health.
ALT Bioscience has completed 3 funding rounds, raising a total of $8.15M. The latest funding stage is Venture round.
Top alternatives and competitors to ALT Bioscience include KTK BIOTECH , PROGEN, Synbiotik Biotechnology, Dollvet, Biomea Fusion. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ALT Bioscience and KTK BIOTECH are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ALT Bioscience, https://www.bouncewatch.com/company/alt-bioscience, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout